Point72 Middle East FZE »

Ironwood Pharmaceuticals shares owned by Point72 Middle East FZE

Quarter-by-quarter ownership of Ironwood Pharmaceuticals (IRWD) shares owned by Point72 Middle East FZE from 13F filings

Historical chart of Point72 Middle East FZE investment in Ironwood Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ironwood Pharmaceuticals held by Point72 Middle East FZE consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ironwood Pharmaceuticals by Point72 Middle East FZE

Quarter filed Position value Share count Share price at filing
2023-12-31 $491k 43k 11.44
2023-09-30 $696k 72k 9.63
2023-03-31 $388k 37k 10.52

More positions owned by Point72 Middle East FZE

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
General Motors Company (GM)
Eli Lilly & Co. (LLY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Caterpillar Call Option (CAT)
UnitedHealth (UNH)
Amazon (AMZN)
Jd.com Spon Adr Cl A (JD)
Lauder Estee Cos Cl A Call Option (EL)
Target Corporation Call Option (TGT)
At&t (T)
Analog Devices Call Option (ADI)
Synopsys (SNPS)

View all positions for Point72 Middle East FZE

Top funds holding Ironwood Pharmaceuticals

Sarissa Capital Management
Vanguard Group
LSV Asset Management
Credit Suisse
Dimensional Fund Advisors
Jacobs Levy Equity Management
Jupiter Asset Management
Point72 Asset Management
Jpmorgan Chase & Co
Man Group
Checkpoint Capital
Two Sigma Advisers
Charles Schwab Investment Management
Hotchkis and Wiley Capital Management
Goldman Sachs Group

View all funds holding Ironwood Pharmaceuticals